Our Approach

Specialty Pharma

Specialty Pharma Defined: Companies focused on drug delivery, biotech and generics, particularly those that rely on in licensing or acquisition for key products.

In this sector, KBL Healthcare Acquisition Corp. III is focused on later-stage specialty pharma companies with revenue and cash flow and more limited exposure to clinical trials and outcomes.

Representative KBL Experience in Specialty Pharma

KBL Case Study: Specialty Pharma

• ISTA Pharmaceuticals is a publicly-traded, ophthalmology-focused pharmaceutical development and marketing company
• ISTA recognized the opportunity to re-start the company in 2002 with new management and a new strategy as a specialty pharma company focused on in-licensing products
• PIPE investment with other prominent VCs
• KBL funds stock sale yielded a 101.8% IRR